Royalty Pharma plc — Director's Dealing 2023

Nov 16, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Royalty Pharma plc (RPRX)
CIK: 0001802768
Period of Report: 2022-12-30

Reporting Person: Legorreta Pablo G. (Director, CEO, Chairman of the Board, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-12-30	Class A ordinary shares	G	292190.49	—	Acquired	292190.49	Indirect
2023-11-16	Class A ordinary shares	J	383000	—	Disposed	63795	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Class A ordinary shares	600000	Indirect
Class A ordinary shares	460139	Indirect
Class A ordinary shares	901590	Indirect
Class A ordinary shares	41306	Indirect
Class A ordinary shares	10000	Indirect
Class A ordinary shares	10000	Indirect
Class A ordinary shares	123310	Indirect
Class A ordinary shares	118500	Indirect
Class A ordinary shares	1040410	Indirect
Class A ordinary shares	6930	Indirect

Footnotes

F1: Represents the transfer by the Reporting Person of Class A ordinary shares for no consideration to RP Management Equity Incentive Plan Trust.

F2: Reflects the exempt transfer pursuant to Rule 16a-13 of Class A ordinary shares from the GST-Exempt Legorreta 2012 Family Trust.